Research Services, Strategic Solutions, Inc. Updates
There are currently over 140 SARS-cov2 vaccine candidates (here’s the full list). Many of those will likely fail at some point due to lack of funding, poor efficacy, or unacceptable side effects but it is hoped that sufficient number will complete phase III trials and...
Events, Research Services, Strategic Solutions, Inc. Updates
What Happens Next for the USA? While there are a great many more blogs to write about COVID-10 from my perspective, before we go any further, we need to have an in-depth discussion on the epidemiology of the virus, so some things that weren’t clear to you now will be,...
Events, Research Services
You’ve spent a lot of time and effort conducting a clinical study and now you find that it’s flawed either when it comes time to try and get it published, or because a systematic reviewer finds the problems. It doesn’t have to be this way. Most clinicians aren’t...